September 23, 2017

VIMPAT Receives EU Approval for Expanded Pediatric Use

News

The European Commission has approved the expansion of the use of UCB’s VIMPAT (lacosamide) to include monotherapy and adjunctive therapy of partial-onset (focal) seizures in children aged 4 years and older. This ... Read more

July 24, 2017

Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs

News

Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells (iPSCs). The model, which researchers refer to as a “seizure-in-a-dish” ... Read more

July 21, 2017July 21, 2017

Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say

News

Doctors have several anti-seizure options to treat epilepsy, but little data exists to show which of these treatments is best for children. Nevertheless, according to a recent study on ... Read more

July 19, 2017July 19, 2017

EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women

News

The European Medicines Agency has scheduled an unprecedented public hearing in September on whether epilepsy therapies that contain sodium valproate pose a risk to pregnant women. It will be the first time the European ... Read more

July 17, 2017

MRI-Guided Laser Technique May Be Potential Surgery Treatment for Certain Epilepsy Patients, Review Says

News

A technique called MRI-guided laser interstitial thermal therapy (MgLiTT) may be a potential treatment for epilepsy patients, according to a recent review. Researchers say that MgLiTT may be a ... Read more

July 14, 2017

Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes

News

The National Institutes of Health has awarded a $3.4 million grant to a Cleveland Clinic-led research collaboration whose objective is to come up with a more comprehensive model for predicting epilepsy ... Read more

July 12, 2017July 17, 2017

Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds

News

Researchers studied the medical records of patients with drug-resistant focal epilepsy who underwent surgery for the disorder at the age of 50 or older and found that the treatment was ... Read more

July 10, 2017July 10, 2017

Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records

News

An ultra-marathon cyclist with epilepsy has broken world indoor-track records for the longest distances covered in six and eight hours. Katie Ford dedicated the records she broke on July 2 ... Read more

July 5, 2017

LivaNova’s VNS Therapy for Medication-Resistant Epilepsy Approved for Young Children

News

The U.S. Food and Drug Administration (FDA) recently approved LivaNova’s VNS Therapy Systems for the treatment of drug-resistant partial onset epileptic seizures in children as young as 4, making ... Read more

June 30, 2017June 30, 2017

Zebinix/Aptiom Does Not Reduce Cognition in Epileptic Children, Phase 2 Clinical Trial Indicates

News

The epilepsy therapy known as Zebinix in Europe and Aptiom in the United States does not impair cognition in children, a Phase 2 clinical trial indicates. Children with focal epilepsy ... Read more

June 28, 2017June 28, 2017

Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows

News

Almost half of epilepsy patients surveyed in a British poll say they’ve forgotten to take their medications at least once in the past month. Researchers at Epilepsy Research UK wanted to ... Read more

June 26, 2017June 26, 2017

LivaNova’s VNS Therapy Systems Approved for Use with MRI Brain Scans

News

The U.S. Food and Drug Administration has granted expanded approval to LivaNova’s VNS Therapy Systems for people with drug-resistant epilepsy that allows use with magnetic resonance imaging (MRI) of the brain, ... Read more